Michael Ofoe Adinku

The researcher has focused on integrating diverse aspects of cancer biology, including molecular genetics, epigenetics, therapeutic treatments, and population-specific challenges. Their work spans themes such as triple-negative breast cancer through patient-derived tumors, BRCA mutations in genetic risk assessment, epigenetic modifications influencing gene expression, the role of DNA methylation in signaling pathways, and treatment outcomes in diverse populations like Europeans, Africans, and Europeans affected by oesophageal issues. Key findings emphasize the importance of combining genomics with molecular pathways to predict tumor progression and evaluate therapeutic efficacy across these themes, aiming for comprehensive approaches that address genetic mutations, epigenetic changes, and therapeutic interventions in patient-specific contexts.